YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFKS9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,259
Award facts
- Contract value 100% obligated
- $1,259.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,259.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. This firm fixed-price delivery order, issued on January 15, 2026, with an ultimate completion date of February 6, 2026, contains no set-aside designation, indicating the contractor competed in unrestricted federal procurement. The order will be performed at the contractor's Park Ridge location and represents a routine pharmaceutical supply transaction within DMS Pharmaceutical Group's established federal contracting portfolio.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy. The parent IDC, valued at $499.999 billion and effective through December 31, 2036, authorizes DLA to issue delivery orders for pharmaceuticals and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's designation as a regional prime vendor contractor, combined with its demonstrated performance across diverse pharmaceutical categories including vaccines, biologics, and specialty medications, positions the company as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FFKS9?
SPE2DR26FFKS9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FFKS9 worth?
The government has obligated $1,259 on SPE2DR26FFKS9.
Is contract SPE2DR26FFKS9 an order under another contract?
Yes. SPE2DR26FFKS9 is a delivery order under SPE2DR25D9212, an indefinite delivery contract.
Was contract SPE2DR26FFKS9 competed?
The extent of competition for SPE2DR26FFKS9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award